Rapid Diagnostic

Human Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1)/ Alpha-Fetoprotein (AFP) Combo Rapid Test

Name: Human Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1)/ Alpha-Fetoprotein (AFP) Combo Rapid Test
Brand: reOpenTest
SKU: PNH-IA2
Availability: InStock

Simultaneous detection of IGFBP-1 and AFP for comprehensive women's health assessment.

CE Certified

ISO 13485

Request Quote View Specs

Main image of Human Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1)/ Alpha-Fetoprotein (AFP) Combo Rapid Test

Why Choose reOpenTest Women's Health & Reproduction Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Dual Detection

Simultaneously detects IGFBP-1 and AFP for comprehensive assessment.

Rapid Results

Provides results in 10-15 minutes for timely decision-making.

User-Friendly

Simple procedure and easy-to-interpret results.

Product Overview

The Human Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1)/ Alpha-Fetoprotein (AFP) Combo Rapid Test is an in-vitro diagnostic device for the simultaneous qualitative detection of IGFBP-1 and AFP in serum or plasma. Elevated levels can indicate malnutrition, metabolic disorders, or liver cancer risks. This test aids healthcare professionals in assessing risks and planning treatment.

Technical Specifications

Detection Target	IGFBP-1 and AFP
Sample Type	Serum or Plasma
Methodology	Immunochromatography
Detection Range	Qualitative (Positive/Negative)
Reaction Time	10-15 minutes
Storage Conditions	2-30u00b0C
Shelf Life	24 months

Procedure & Interpretation

Step-by-Step Procedure

Add the appropriate amount of serum/plasma sample to the test cassette.
Wait for 10-15 minutes.
Read and interpret the results based on the appearance of control and test lines.

Result Interpretation

Positive: Appearance of both control and test lines indicates a positive result for either IGFBP-1 or AFP.

Negative: Appearance of only the control line indicates a negative result for both IGFBP-1 and AFP.

Invalid: If the control line does not appear, the test is invalid and should be repeated.

Frequently Asked Questions

A positive result suggests elevated levels of either IGFBP-1 or AFP, potentially indicating malnutrition, metabolic disorders, or increased risk of liver cancer/germ cell tumors. Further clinical evaluation is recommended.

This rapid test is designed for high sensitivity and specificity. However, as with any diagnostic test, results should be interpreted in conjunction with other clinical information and confirmatory testing.

No, this test is intended for use by trained healthcare professionals in a clinical or laboratory setting.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Human Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1)/ Alpha-Fetoprotein (AFP) Combo Rapid Test